Search | Page 4 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Alternative Donor Transplantation with High-Dose Post-Transplantation Cyclophosphamide for Refractory Severe Aplastic Anemia

    ... Journal Title:  Biol Blood Marrow Transplant Primary ... was 25 (range, 2 to 58) days, and to last platelet transfusion to keep platelets counts over 50 × 103/mm3 was 27.5 ...

    Research Article last updated 01/24/2017 - 10:04am.

  2. Efficacy and Safety of Lenalidomide for Treatment of Low-/Intermediate-1-Risk Myelodysplastic Syndromes with or without 5q Deletion: A Systematic Review and Meta-Analysis

    ... Lenalidomide could effectively induce red blood cell (RBC) transfusion independence (TI) in patients with lower-risk ...

    Research Article last updated 11/28/2016 - 9:36am.

  3. Development and validation of a model to predict platelet response to romiplostim in patients with lower-risk myelodysplastic syndromes

    ... endogenous erythropoietin levels and limited red blood cell transfusion history can predict response to erythropoiesis-stimulating agents ... Variables including baseline endogenous THPO levels, transfusion needs, and platelet response were analysed in a randomized trial ...

    Research Article last updated 08/04/2014 - 8:33am.

  4. MDS Follows Two Misdiagnoses

    ... I would no longer have vision insurance. The eye doctor saw blood in my eyes and sent me for more tests and a complete blood count ... for two pills a day instead of one.  I also had a blood transfusion yesterday and this time is was after 6 weeks. Since I had a bad ...

    Patient Chronicle last updated 12/27/2016 - 7:23am.

  5. Prophylactic RhCE and Kell antigen matching: impact on alloimmunization in transfusion-dependent patients with myelodysplastic syndromes

    ... patients with myelodysplastic syndromes (MDS) become transfusion-dependent and are at risk for red blood cell (RBC) alloimmunization. This study compared alloimmunization ...

    Research Article last updated 02/03/2017 - 11:00am.

  6. Design and rationale of the QUAZAR Lower-Risk MDS (AZA-MDS-003) trial: a randomized phase 3 study of CC-486 (oral azacitidine) plus best supportive care vs placebo plus best supportive care in patients with IPSS lower-risk myelodysplastic syndromes and po

    ... thrombocytopenia who may have required red blood cell or platelet transfusions. The overall response rate was ... hematologic improvement in 28 % of patients and RBC transfusion independence sustained for 56 days in 47 % of patients with ...

    Research Article last updated 06/23/2016 - 10:17am.

  7. Polymorphism of the complement receptor 1 gene correlates with hematological response to eculizumab in patients with paroxysmal nocturnal hemoglobinuria

    ... the response is variable and some patients remain red blood cell transfusion -dependent. In 72 patients with hemolytic Paroxysmal Nocturnal ...

    Research Article last updated 09/26/2013 - 3:28pm.

  8. Patient Inspires Workplace Giving

    ... other patients, we first knew something wasn’t right when blood work from a routine physical showed significantly low blood cell counts. ... tell me to get to a hospital emergency room for a blood transfusion right away. After my first blood transfusion, I saw a ...

    Patient Chronicle last updated 06/28/2016 - 8:12am.

  9. Blood Transfusions

    Blood Transfusions A transfusion usually involves only certain parts of blood. These might be the red blood cells, platelets or plasma . Rarely ...

    Topic section last updated 03/29/2016 - 7:17pm.

  10. NHLBI profiles a member of the Foundation’s patient community.

    ... Article Link:  Tenacity Topples Transfusion: How One Woman’s Determination Helped Her Defeat a Devastating Blood Disease Article Source:  ...

    Article last updated 06/13/2016 - 1:51pm.